Analysis of cardiac function during hyperacute rejection: effects of PAF antagonist, TXA(2) inhibitor/antagonists, and nitroglycerin.
Miyatake
T
T
Departments of Cardiovascular Surgery, Laboratory Medicine and Anatomy, Hokkaido University School of Medicine, Sapporo, Japan.
Kubota
S
S
Miyazaki
K
K
Watanabe
S
S
Mafune
N
N
Murashita
T
T
Yasuda
K
K
D000818:Animals; D004558:Electric Stimulation; D004791:Enzyme Inhibitors / Q000494:pharmacology; D005229:Fatty Acids, Monounsaturated / Q000494:pharmacology; D006084:Graft Rejection / Q000503:physiopathology*; D006168:Guinea Pigs; D016027:Heart Transplantation / Q000502:physiology*; D066298:In Vitro Techniques; D007546:Isoquinolines / Q000494:pharmacology*; D005996:Nitroglycerin / Q000494:pharmacology*; D010972:Platelet Activating Factor / Q000037:antagonists & inhibitors; D010975:Platelet Aggregation Inhibitors / Q000494:pharmacology; D011725:Pyridines / Q000494:pharmacology; D011726:Pyridinium Compounds / Q000494:pharmacology*; D051381:Rats; D011919:Rats, Inbred Strains; D044005:Tetrahydroisoquinolines; D013928:Thromboxane A2 / Q000031:analogs & derivatives* / Q000037:antagonists & inhibitors / Q000494:pharmacology; D014183:Transplantation, Heterologous / Q000502:physiology*; D016277:Ventricular Function, Left / Q000187:drug effects / Q000502:physiology*
D004791:Enzyme Inhibitors; D005229:Fatty Acids, Monounsaturated; D007546:Isoquinolines; D010972:Platelet Activating Factor; D010975:Platelet Aggregation Inhibitors; D011725:Pyridines; D011726:Pyridinium Compounds; D044005:Tetrahydroisoquinolines; D013928:Thromboxane A2; C049855:ONO 3708; D005996:Nitroglycerin; C045446:isbogrel; C067430:TCV 309